Anemia and diabetes

American Journal of Nephrology

Volumn 24, Issue 5, 2004, Pages 522-526

  Deray, G ^a   Heurtier, A ^a   Grimaldi, A ^a   Launay Vacher, V ^a   Isnard Bagnis, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Anemia; Diabetes; Erythropoietin; Hemoglobin; Renal failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; INSULIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CARDIOVASCULAR DISEASE; COMORBIDITY; DEVELOPING COUNTRY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HORMONE DEFICIENCY; HOSPITAL ADMISSION; HUMAN; HYPOXIA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIFESTYLE; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; STATISTICS; WORLD HEALTH ORGANIZATION;

ANEMIA; DIABETES COMPLICATIONS; HUMANS; KIDNEY FAILURE; PREVALENCE;

EID: 10644239782     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081058     Document Type: Review

References (42)

1. Ritz E, Rychlik I, Locatelli F, Halimi S: End stage renal failure in type 2 diabetes: A medical catastrophe of worldwide/dimensions. Am J Kidney Dis 1999;34:795-808.
2. Chantrel F, Enache I, Boullier M, et al: Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant 1999;14:129-136.
3. Bosman D, Winkler A, Marsden J, et al: Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001;24:495-499.
4. Inomata S, Itoh M, Imai H, Sato T: Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997;75:426-430.
5. Ishimura E, Okumo S, et al: Diabetes mellitus increases the severity of anemia in non dialyzed patients with renal failure. J Nephrol 1998;11:83-86.
6. Dikow R, Schwenger V, Schömig M, Ritz E: How should we manage anemia in patients with diabetes? Nephrol Dial Transplant 2002;17(S):67-72.
7. Kazmi WH, Annamaria TK, Khan S, Abichandan I, Ruthazer R, Obrador G, Pereira BJG: Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis 2001;38:803-812.
8. Valderrabano F, Hörl WH, MacDougall IC, Rossert J, Rutowski B, Wauters JP: Pre-dialysis survey on anemia management. Nephrol Dial Transplant, 2003;18:89-100.
9. Jungers PY, Robino C, Choukroun G, Nguyen-Khoa T, Massy ZA, Jungers P: Incidence of anemia, and use of epoetin therapy in pre-dialysis patients: A prospective study in 403 patients. Nephrol Dial Transplant 2002;17:1621-1627.
10. Thomas CM, MacIsaac RJ, Tsalamandris C, Power D, Jerums G: Unrecognized anemia in patients with diabetes. Diabetes Care 2003;26:1164-1169.
11. Astor BC, Muntner P, Levin A, Eristace JA, Coresh J: Association of kidney function with anemia: the third national health and nutrition examination survey (1988-1994). Arch Intern Med 2002;162:1401-1408.
12. Thomas MC, MacIsaac RJ, Tsalamandris C, Molyneaux L, Gombina I, Fulchez G, Yve D, Jerums G: The Burden of anemia in type 2 diabetes and the role of nephropathy: A cross-sectional study. Nephrol Dial Transpl 2004;19:1792-1797.
13. Stevens PE, Didonoghue DJ, Lameire NR: Anemia in patients with diabetics: Unrecognized, undetected and untreated; Curr Med Res Op 200;19:395-401.
14. Takaku F, Hirasima K, Okinaka S: Effects of the bilateral section of the splanchnic nerve in erythropoiesis. Nature 1961;191:500-501.
15. Beynon G: The influence of the autonomic nervous system in the control of the erythropoietin secretion in the hypoxic rat. J Physiol 1977;266:347-360.
16. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ: Erythropoietin depletion and anemia in diabetes mellitus. Diab Med 1999;16:813-819.
17. Rarick MU, Espina BM, Colley DT, Chrusoki E, Gandara S, Feinstein DI: Treatment of a unique anemia in patients with IDDM with erythropoietin-alpha. Diab Care 1998;21:423-426.
18. Ricerca BM, Todaro L, Caduto S, Cotroneo P, Damiani P, Manto A, Pitocco D, Storti S, Ghirlanda G: Blunted erythropoietin response to anemia in type 1 diabetic patients disease. Blood 1992;80:1639-1647.
19. Jeffrey RF, Kendall RG, Prabhu O, Norfolk DR, Will EJ, Davison AM: Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation. Clin Nephrol 1995;44:241-247.
20. Means RT, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639-1647.
21. Donnelly S, Shah BR: Erythropoietin deficiency in hyporeninemia. Am J Kidney Dis 1999;33:947-953.
22. Bayes B, Serra A, Junca J, Lanzurica R: Successful treatment of anemia of nephritic syndrome with recombinant erythropoietin. Nephrol Dial Transplant 1998;13:1894-1895.
23. Qiao Q, Keinanen F, Kiukanniemi S, Laara E: The relationship between haemoglobin levels and diabetic retinopathy. J Clin Epidemiol 1997;50:153-158.
24. Davis M, Fisher M, Gangnon R, et al: Risk factors for high risk proliferative retinopathy study report. Invest Ophtalmol Vis Sci 1998;39:233-252.
25. Shorb S: Anemia and diabetic retinopathy. Am J Ophthalmol 1985;100:434-436.
26. Friedman E, Brown C, Berman D: Erythropoietin in diabetic macular oedema and renal insufficiency. Am J Kidney Dis 1995;26:202-208.
27. Barnes AJ, Locke P, Sendder PR, Dormandy TL, Dormangy JA, Slack J: Hyperviscosity: A treatable component of diabetic microcirculatory. Lancet 1977;15:789-902.
28. Mc Millan DE, utterback NG, Puma JL, Barbara S: Reduced erytrocytes deformability in diabetes. Diabetes 1978;27:895-901.
29. Sinclair S: Macular retinal capillary hemodynamics in diabetic patients. Ophthalmology 1991;98:1580-1586.
30. Sinclair S, Mainster M: Diabetic macular edema: New concepts of pathology and treatment (Editorial). Semin Ophthalmol 1999;14:197-199.
31. Benjamin L: Glucose, VEGF-A and diabetic complications. Am J Pathol 2001;158:1181-1184.
32. Kuriyama S, Tomonari H, Yoshida H, Hasimoto T, Kawagushi Y, Sakai O: Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in non diabetic patients. Nephron 1997;77:176-185.
33. Ueda I, Shoji T, Emoto M, Morioka T, Matsumoto N, Fukumoto S, Miki T, Inaba M, Nishizawa Y: Factors affecting progression of renal failure in patients with type 2 diabetes. Diab Care 2003;26:1530-1534.
34. Silverberg DS, Wexler D, Blum WD, Tchebiner JZ, Shops D, Keren G, Schwatz D, Baruch R, Yachnin T; Shraked M, Schwartz I, Steinbruch S, Taina A: The effect of correction of anemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003;17:141-146.
35. Foley RN: Cardiac disease in diabetic endstage renal disease. Diabetologia 1997;40:1307-1312.
36. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelsshon D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjen O: Left ventricular mass index increase in early renal disease: Impact of decline in haemoglobin. Am J Kidney Dis 1999;34:125-134.
37. Portoles J: Cardiovascular effects of recombinant human erythropoietin in pre-dialysis patients. Am J Kidney Dis 1997;29:541-548.
38. Hayashi T: Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in pre-dialysis patients with chronic renal failure. Am J Kidney Dis 2000;35:250-256.
39. Revised European Best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transpl 2004;19(S2):ii1-ii47.
40. Besarab A, Bolton WK, Browne JK, et al: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-590.
41. Furuland H, Luige T, Alhmen J, Christensson A, Strombom U, Danielson BG: A randomized controlled trial of haemoglobin normalization with erythropoietin-alpha in pre-dialysis and dialysis patients. Nephrol Dial Transplant 2003;28:353-361.
42. Laville M: New strategies in anemia management. ACORD (Anemia Correction in Diabetes) trial. Acta Diabetol 2004;41(S1):S18-S22.